| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1048 |
| 1 | INFLIXIMAB | 779 |
| 2 | ADALIMUMAB-ADAZ | 433 |
| 3 | PREDNISONE | 425 |
| 4 | ADALIMUMAB-AATY | 414 |
| 5 | ADALIMUMAB-FKJP | 412 |
| 6 | METHOTREXATE SODIUM | 365 |
| 7 | METHOTREXATE | 315 |
| 8 | PREDNISOLONE | 294 |
| 9 | PREDNISOLONE ORAL | 294 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VILOBELIMAB | 1 | 0.3333 |
| 1 | COCAINE HYDROCHLORIDE NASAL | 3 | 0.0462 |
| 2 | COUMARIN | 5 | 0.0305 |
| 3 | HYDROCORTISONE ACETATE, IODOQUINOL | 1 | 0.0303 |
| 4 | DIFLORASONE DIACETATE | 2 | 0.0104 |
| 5 | ADALIMUMAB-AQVH | 1 | 0.0101 |
| 6 | CALCIPOTRIENE CREAM, 0.005% | 1 | 0.0097 |
| 7 | ADALIMUMAB-FKJP | 412 | 0.0090 |
| 8 | ADALIMUMAB-AATY | 414 | 0.0083 |
| 9 | ADALIMUMAB-ADAZ | 433 | 0.0079 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1389 |
| 1 | Corticosteroid [EPC] | 876 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 316 |
| 3 | Interleukin-23 Antagonist [EPC] | 259 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 233 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 186 |
| 6 | Interleukin-12 Antagonist [EPC] | 183 |
| 7 | Integrin Receptor Antagonist [EPC] | 174 |
| 8 | Purine Antimetabolite [EPC] | 170 |
| 9 | Aminosalicylate [EPC] | 157 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 54 | 0.0050 |
| 1 | Interleukin-17A Antagonist [EPC] | 150 | 0.0040 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 8 | 0.0039 |
| 3 | Provitamin D2 Compound [EPC] | 91 | 0.0031 |
| 4 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 5 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 6 | Interleukin-23 Antagonist [EPC] | 259 | 0.0025 |
| 7 | Blood Viscosity Reducer [EPC] | 10 | 0.0023 |
| 8 | Integrin Receptor Antagonist [EPC] | 174 | 0.0020 |
| 9 | Interleukin-12 Antagonist [EPC] | 183 | 0.0018 |